671 studies found for:    Open Studies | "Carcinoid Tumor"
Show Display Options
Rank Status Study
21 Recruiting RegisterNET - A Registry for Neuroendocrine Tumors in the USA
Conditions: Neuroendocrine Tumor;   Carcinoid;   Neuroendocrine Carcinoma
Intervention: Device: NETest
22 Available Gallium-68 DOTATOC for Management of Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: Gallium-68 DOTATOC
23 Available 68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)
Conditions: Carcinoid Cancer;   Neuroendocrine Tumors;   Medullary Thyroid Cancer;   Cancers Expressing Somatostatin Receptors
Intervention: Drug: 68Ga DOTATATE
24 Recruiting Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: Recombinant anti-tumor and anti-virus protein for injection (Novaferon)
25 Recruiting Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors
Conditions: Neuroendocrine Tumors;   Pancreatic Neuroendocrine Tumors
Intervention:
26 Not yet recruiting Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study
Conditions: Midgut Neuroendocrine Tumours;   Pancreatic Neuroendocrine Tumours
Interventions: Drug: octreotate;   Drug: Capecitabine;   Drug: Temozolomide
27 Recruiting Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors
Conditions: Gastrointestinal Tumors;   Pancreatic Tumors;   Gastrointestinal Neuroendocrine Tumors;   Pancreatic Neuroendocrine Tumors
Intervention: Drug: Everolimus
28 Recruiting A Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors
Conditions: Neuroendocrine Tumors;   Liver Metastases
Intervention: Drug: 177Lu-DOTA-TATE
29 Not yet recruiting Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors
Condition: Small-intestine Neuroendocrine Tumors (Carcinoid Tumors)
Intervention: Biological: blood sample withdrawn
30 Unknown  Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors
Condition: Neuroendocrine Tumor
Intervention: Procedure: PET scan with Ga68-DOTANOC
31 Recruiting Best Therapy for Patients With Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention:
32 Not yet recruiting The Indol Profile; Exploring the Metabolic Profile of Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Other: vena punction
33 Unknown  ProGRP, CgA, NSE and TUM2-PK in in Patients With Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention:
34 Recruiting 5-HIAA in Urine Versus 5-HIAA in Plasma Patients With a Serotonin Producing Neuroendocrine Tumor'
Condition: Neuroendocrine Tumors
Intervention:
35 Recruiting Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study
Condition: Neuroendocrine Tumor
Intervention: Other: Videoconsultation
36 Unknown  68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours
Condition: Neuroendocrine Tumours
Intervention: Drug: Diagnostic work up
37 Recruiting Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Interventions: Drug: 177Lu-DOTATATE 25.9 GBq activity;   Drug: 177Lu-DOTATATE 18.5 GBq activity
38 Recruiting Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE)
Conditions: Liver;   Metastasis;   Neuroendocrine Tumors
Interventions: Radiation: 177Lutetium;   Procedure: Liver transplantation
39 Recruiting Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients
Condition: NeuroEndocrine Tumours
Intervention: Drug: lanreotide acetate
40 Recruiting Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: Lutetium-177 Octreotate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years